Topics

$MRK EC Approves DELSTRIGO™ a Once-Daily Fixed-Dose Combination Tablet as a Complete Regimen and PIFELTRO™ an NNRTI, Both for the Treatment of HIV-1 in Appropriate Patients

16:31 EST 28 Nov 2018 | Odi Bruckman

EC Approves DELSTRIGO™ a Once-Daily Fixed-Dose Combination Tablet as a Complete Regimen and PIFELTRO™ an NNRTI, Both for the Treatment of HIV-1 in Appropriate Patients

Original Article: $MRK EC Approves DELSTRIGO™ a Once-Daily Fixed-Dose Combination Tablet as a Complete Regimen and PIFELTRO™ an NNRTI, Both for the Treatment of HIV-1 in Appropriate Patients

NEXT ARTICLE

More From BioPortfolio on "$MRK EC Approves DELSTRIGO™ a Once-Daily Fixed-Dose Combination Tablet as a Complete Regimen and PIFELTRO™ an NNRTI, Both for the Treatment of HIV-1 in Appropriate Patients"

Quick Search